Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...

Before Rhodes could speak, Orton's music hit. The Viper put over Rhodes for beating Jey Uso to get to the finals before the ...

Night of Champions 2025 in Riyadh witnessed unexpected crowd reactions, defying typical wrestling event norms. John Cena ...

Currently, PET scanner validation phantoms, methods, and acceptance criteria for clinical trials are not standardized. This situation generates substantial inefficiencies with many scanners being ...

Nonprofit leaders spoke of the potential consequences of less federal funding for food assistance and medical care.

Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...

Specifically, she has a record of successfully commercialising oncology therapies, such as Erbitux, Inlyta, Onivyde, and Akynzeo, as well as developing new indications for in-market therapies.

Mid North Coast resident Shirley Kent wants to help break down the stigma for women battling gynaecological cancer.

Almost 80% of children with cancer in resource-rich countries can be cured by timely, intensive multimodality treatment and robust supportive care.1,2 However, only 20% of the world's children with ...